Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Cash from Investing Activities (2016 - 2026)

Orthofix Medical has reported Cash from Investing Activities over the past 17 years, most recently at -$10.5 million for Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities fell 56.1% year-over-year to -$10.5 million, compared with a TTM value of -$38.4 million through Mar 2026, down 63.66%, and an annual FY2025 reading of -$34.6 million, down 25.45% over the prior year.
  • Cash from Investing Activities came in at -$10.5 million for Q1 2026, up from -$10.9 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $17.1 million in Q1 2023 to a low of -$22.3 million in Q3 2023.
  • Median Cash from Investing Activities over the past 5 years was -$7.5 million (2022), compared with a mean of -$7.7 million.
  • The sharpest move saw Cash from Investing Activities soared 401.46% in 2023, then plummeted 857.8% in 2025.
  • Over 5 years, Cash from Investing Activities stood at -$5.9 million in 2022, then crashed by 155.14% to -$15.1 million in 2023, then skyrocketed by 92.46% to -$1.1 million in 2024, then plummeted by 857.8% to -$10.9 million in 2025, then rose by 3.27% to -$10.5 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Cash from Investing Activities are -$10.5 million (Q1 2026), -$10.9 million (Q4 2025), and -$9.9 million (Q3 2025).